A Prospective Phase II Multicenter Study for Prophylaxis of Acute Exacerbations of Interstitial Lung Disease after Lung Cancer Resectio
Phase 2
- Conditions
- Interstitial pneumonia Lung cancer
- Registration Number
- JPRN-UMIN000008277
- Lead Sponsor
- Yokohama Consortium of Thoracic Surgeons
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1)History of cancer treatment within 5 years (except carcinoma in situ). History of radiation therapy (which include a lung in the treatment field) or chemotherapy. 2)Severe comorbidities (uncontrolled ischemic heart disease or myocardial infarction within three months. Uncontrolled diabetes, hypertension and infection) 3)Pregnant ladies, nursing ladies, the ladies with possibility of pregnancy. 4)Patients who takes steroid therapy 5)Treatment history of interstitial pneumonia with pirfenidone.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method